Works matching IS 00070920 AND DT 2014 AND VI 110 AND IP 10

Results: 30

The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.

Published in:

2014

By:

Ling, A;
Edin, S;
Wikberg, M L;
Oberg, A;
Palmqvist, R;
Öberg, Å

Publication type:

journal article

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.

Published in:

2014

By:

Han, S;
Zhang, C;
Li, Q;
Dong, J;
Liu, Y;
Huang, Y;
Jiang, T;
Wu, A

Publication type:

journal article

Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2537, doi. 10.1038/bjc.2014.159

By:

Sanjmyatav, J;
Matthes, S;
Muehr, M;
Sava, D;
Sternal, M;
Wunderlich, H;
Gajda, M;
Grimm, M-O;
Junker, K

Publication type:

Article

Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2472, doi. 10.1038/bjc.2014.204

By:

Lee, J-L;
Ahn, J-H;
Choi, M K;
Kim, Y;
Hong, S-W;
Lee, K-H;
Jeong, I-G;
Song, C;
Hong, B-S;
Hong, J H;
Ahn, H

Publication type:

Article

Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2412, doi. 10.1038/bjc.2014.206

By:

Gunsoy, N B;
Garcia-Closas, M;
Moss, S M

Publication type:

Article

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2389, doi. 10.1038/bjc.2014.191

By:

Nomiya, T;
Tsuji, H;
Maruyama, K;
Toyama, S;
Suzuki, H;
Akakura, K;
Shimazaki, J;
Nemoto, K;
Kamada, T;
Tsujii, H

Publication type:

Article

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2441, doi. 10.1038/bjc.2014.194

By:

Lankheet, N A G;
Kloth, J S L;
Gadellaa-van Hooijdonk, C G M;
Cirkel, G A;
Mathijssen, R H J;
Lolkema, M P J K;
Schellens, J H M;
Voest, E E;
Sleijfer, S;
de Jonge, M J A;
Haanen, J B A G;
Beijnen, J H;
Huitema, A D R;
Steeghs, N

Publication type:

Article

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2506, doi. 10.1038/bjc.2014.178

By:

Toyoda, M;
Kaira, K;
Ohshima, Y;
Ishioka, N S;
Shino, M;
Sakakura, K;
Takayasu, Y;
Takahashi, K;
Tominaga, H;
Oriuchi, N;
Nagamori, S;
Kanai, Y;
Oyama, T;
Chikamatsu, K

Publication type:

Article

Multipoint targeting of the PI3K/mTOR pathway in mesothelioma.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2479, doi. 10.1038/bjc.2014.220

By:

Zhou, S;
Liu, L;
Li, H;
Eilers, G;
Kuang, Y;
Shi, S;
Yan, Z;
Li, X;
Corson, J M;
Meng, F;
Zhou, H;
Sheng, Q;
Fletcher, J A;
Ou, W-B

Publication type:

Article

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2434, doi. 10.1038/bjc.2014.195

By:

Lin, C-C;
Su, W-C;
Yen, C-J;
Hsu, C-H;
Su, W-P;
Yeh, K-H;
Lu, Y-S;
Cheng, A-L;
Huang, D C-L;
Fritsch, H;
Voss, F;
Taube, T;
Yang, J C-H

Publication type:

Article

Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2615, doi. 10.1038/bjc.2014.176

By:

Suspène, R;
Caval, V;
Henry, M;
Bouzidi, M S;
Wain-Hobson, S;
Vartanian, J-P

Publication type:

Article

What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2420, doi. 10.1038/bjc.2014.200

By:

Rothermundt, C;
Whelan, J S;
Dileo, P;
Strauss, S J;
Coleman, J;
Briggs, T W;
Haile, S R;
Seddon, B M

Publication type:

Article

Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2396, doi. 10.1038/bjc.2014.197

By:

Zhu, Z;
Zhang, J;
Liu, Y;
Chen, M;
Guo, P;
Li, K

Publication type:

Article

Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2544, doi. 10.1038/bjc.2014.170

By:

Croner, R S;
Geppert, C-I;
Bader, F G;
Nitsche, U;
Späth, C;
Rosenberg, R;
Zettl, A;
Matias-Guiu, X;
Tarragona, J;
Güller, U;
Stürzl, M;
Zuber, M

Publication type:

Article

Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2623, doi. 10.1038/bjc.2014.193

By:

Little, M P;
Schaeffer, M L;
Reulen, R C;
Abramson, D H;
Stovall, M;
Weathers, R;
de Vathaire, F;
Diallo, I;
Seddon, J M;
Hawkins, M M;
Tucker, M A;
Kleinerman, R A

Publication type:

Article

The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2583, doi. 10.1038/bjc.2014.202

By:

Kawatsu, Y;
Kitada, S;
Uramoto, H;
Zhi, L;
Takeda, T;
Kimura, T;
Horie, S;
Tanaka, F;
Sasaguri, Y;
Izumi, H;
Kohno, K;
Yamada, S

Publication type:

Article

Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2593, doi. 10.1038/bjc.2014.201

By:

Yan, J;
De Melo, J;
Cutz, J-C;
Aziz, T;
Tang, D

Publication type:

Article

Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2560, doi. 10.1038/bjc.2014.162

By:

Han, S;
Zhang, C;
Li, Q;
Dong, J;
Liu, Y;
Huang, Y;
Jiang, T;
Wu, A

Publication type:

Article

Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2569, doi. 10.1038/bjc.2014.165

By:

Boudreau, H E;
Casterline, B W;
Burke, D J;
Leto, T L

Publication type:

Article

Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2531, doi. 10.1038/bjc.2014.180

By:

Dalpiaz, O;
Pichler, M;
Mannweiler, S;
Martín Hernández, J M;
Stojakovic, T;
Pummer, K;
Zigeuner, R;
Hutterer, G C

Publication type:

Article

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2462, doi. 10.1038/bjc.2014.181

By:

Lin, H-M;
Castillo, L;
Mahon, K L;
Chiam, K;
Lee, B Y;
Nguyen, Q;
Boyer, M J;
Stockler, M R;
Pavlakis, N;
Marx, G;
Mallesara, G;
Gurney, H;
Clark, S J;
Swarbrick, A;
Daly, R J;
Horvath, L G

Publication type:

Article

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2524, doi. 10.1038/bjc.2014.163

By:

Krenn-Pilko, S;
Langsenlehner, U;
Thurner, E-M;
Stojakovic, T;
Pichler, M;
Gerger, A;
Kapp, K S;
Langsenlehner, T

Publication type:

Article

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2450, doi. 10.1038/bjc.2014.168

By:

Abdel-Fatah, T M A;
McArdle, S E B;
Johnson, C;
Moseley, P M;
Ball, G R;
Pockley, A G;
Ellis, I O;
Rees, R C;
Chan, S Y T

Publication type:

Article

Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2496, doi. 10.1038/bjc.2014.177

By:

Jiang, G;
Yang, C-S;
Xu, D;
Sun, C;
Zheng, J-N;
Lei, T-C;
Liu, Y-Q

Publication type:

Article

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2405, doi. 10.1038/bjc.2014.192

By:

Shaw, G L;
Thomas, B C;
Dawson, S N;
Srivastava, G;
Vowler, S L;
Gnanapragasam, V J;
Shah, N C;
Warren, A Y;
Neal, D E

Publication type:

Article

The intratumoural subsite and relation of CD8+ and FOXP3+ T lymphocytes in colorectal cancer provide important prognostic clues.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2551, doi. 10.1038/bjc.2014.161

By:

Ling, A;
Edin, S;
Wikberg, M L;
Öberg, Å;
Palmqvist, R

Publication type:

Article

Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2604, doi. 10.1038/bjc.2014.160

By:

Jørgensen, A;
Young, J;
Nielsen, J E;
Joensen, U N;
Toft, B G;
Rajpert-De Meyts, E;
Loveland, K L

Publication type:

Article

Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2489, doi. 10.1038/bjc.2014.169

By:

Azimi, A;
Pernemalm, M;
Frostvik Stolt, M;
Hansson, J;
Lehtiö, J;
Egyházi Brage, S;
Hertzman Johansson, C

Publication type:

Article

Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2514, doi. 10.1038/bjc.2014.153

By:

Xie, G;
Ji, A;
Yuan, Q;
Jin, Z;
Yuan, Y;
Ren, C;
Guo, Z;
Yao, Q;
Yang, K;
Lin, X;
Chen, L

Publication type:

Article

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.

Published in:

British Journal of Cancer, 2014, v. 110, n. 10, p. 2427, doi. 10.1038/bjc.2014.208

By:

Ediebah, D E;
Coens, C;
Zikos, E;
Quinten, C;
Ringash, J;
King, M T;
Schmucker von Koch, J;
Gotay, C;
Greimel, E;
Flechtner, H;
Weis, J;
Reeve, B B;
Smit, E F;
Taphoorn, M J B;
Bottomley, A

Publication type:

Article

Works matching IS 00070920 AND DT 2014 AND VI 110 AND IP 10

The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma.

Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISH.

Gemcitabine-oxaliplatin plus prednisolone is active in patients with castration-resistant prostate cancer for whom docetaxel-based chemotherapy failed.

Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom.

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.

Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.

Multipoint targeting of the PI3K/mTOR pathway in mesothelioma.

A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies.

Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics.

What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.

Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis.

Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.

Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US-UK study.

The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma.

Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.

Tumour-infiltrating CD4<sup>+</sup> and CD8<sup>+</sup> lymphocytes as predictors of clinical outcome in glioma.

Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells.

Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.

Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.

The intratumoural subsite and relation of CD8<sup>+</sup> and FOXP3<sup>+</sup> T lymphocytes in colorectal cancer provide important prognostic clues.

Hanging drop cultures of human testis and testis cancer samples: a model used to investigate activin treatment effects in a preserved niche.

Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.

Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.